Wei Lin
Chief Tech/Sci/R&D Officer bei REVOLUTION MEDICINES, INC.
Vermögen: 3 Mio $ am 31.03.2024
Aktive Positionen von Wei Lin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| 2SEVENTY BIO, INC. | Director/Board Member | 07.03.2023 | - |
| Independent Dir/Board Member | 07.03.2023 | - | |
| REVOLUTION MEDICINES, INC. | Chief Tech/Sci/R&D Officer | 01.04.2023 | - |
Karriereverlauf von Wei Lin
Ehemalige bekannte Positionen von Wei Lin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ERASCA, INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 | 10.04.2023 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 14.11.2018 | 05.01.2021 |
| Roche (China) Co. Ltd. | Corporate Officer/Principal | 01.01.2006 | 01.01.2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Wei Lin
| Haverford College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| China | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| REVOLUTION MEDICINES, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| 2SEVENTY BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Roche (China) Co. Ltd. |
